Recurrence and death in non-small cell lung carcinomas: A prognostic model using pathological parameters, microvessel count, and gene protein products

Clinical Cancer Research

Volumn 2, Issue 6, 1996, Pages 1067-1075

  Fontanini, Gabriella ^a   Vignati, Silvana ^a   Bigini, Daniela ^a   Mussi, Alfredo ^a   Lucchi, Marco ^a   Chiné, Silvana ^a   Angeletti, Carlo Alberto ^a   Bevilacqua, Generoso ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; TUMOR BLOOD FLOW;

AGED; ANTIGENS, NUCLEAR; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICROCIRCULATION; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; REGRESSION ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029891577     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Mountain, C. F. A new international staging system for lung cancer. Chest, 89: 225s-33s, 1986
2. Naruke, T., Goya, T., Tsuchiy, A. R., and Suemasu, K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J. Thorac. Cardiovasc. Surg., 96: 440-447, 1988.
3. Slebos, R. J. C., Kibbelaar, R. E , Dalesio, O., Kooistra, A., Stam, J., Meijer, J. I. M., Wagenaar, S. S., Vanderschueren, R. G. J. R. A., van Zandwijk, N., Wolter, J. M., Bos, J. I., and Rodenhuis, S. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med., 324: 1084-1090, 1991.
4. Quinlan, D. C., Davidson, A. S., Summers, C. L., Warden, H. E., and Doshi, H. M. Accumulation of p53 correlates with a poor prognosis in human lung cancer. Cancer Res., 52: 4828-4831, 1992.
5. Macchiarini, P., Fontanini, G , Hardin, J M., Squartini, F., and Angeletti C. A. Relation of neovascularisation to metastasis of non-small- cell lung cancer. Lancet, 340: 45-46, 1992.
6. Yamasaki, K., Abe, S., Takekawa, W. M., Sukoh, N., Watanabe, N., Ogura, S., Nakajima, I., Isobe, H., Inoue, K., and Kawakami, Y. Tumor angiogenesis in human lung adenocarcinoma. Cancer (Phila.), 54: 2245-2250, 1994.
7. Veale, D., Ken, N., Gibson, J K., Kelly, P. J., and Harris, A. L. The relationship of quantitative epidermal growth factor receptor expression in non small cell lung cancer to long term survival Br. J. Cancer., 68: 162-165, 1993.
8. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
9. Folkman, J., Watson, K., Ingiber, D., and Hanahan, D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (Lond.), 339: 58-61, 1989.
10. Craft, P. S., and Harris, A. L. Clinical prognostic significance of tumour angiogenesis. Ann. Oncol., 5: 305-12, 1994.
11. Fontanini, G., Bigini, D., Vignati, S., Basolo, F., Mussi, A., Lucchi, M., Chiné, S., Angeletti, C. A., and Bevilacqua, G. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J. Pathol., 177: 57-63, 1995.
12. Fontanini, G., Macchiarini, P., Pepe, S., Ruggiero, A., Hardin, M., Bigini, D., Vignati, S., Pingitore, R., and Angeletti, C. A. The expression of proliferating cell nuclear antigen in paraffin sections of peripheral node-negative non-small cell lung cancer. Cancer (Phila.), 70: 1520-1527, 1992.
13. Scagliotti, G. V., Micela, M., Gubetta, L., Leonardo, E., Cappia, S. Borasio, P., and Pozzi, E. Prognostic significance of Ki-67 labeling in resected in non small cell lung cancer. Eur. J. Cancer, 29A: 363-365, 1992.
14. Harpole, D. H., Herdon, J. H., Wolfe, W. G., Iglehart, J. D., and Marks, J. R. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, and oncoprotein expression. Cancer Res., 55: 51-56, 1995.
15. Silvestrini, R., Veneroni, S., Daidone, M. G., Benini, E., Boracchi, P., Mezzetti, M., Di Fronzo, G., Rilke, F., and Veronesi, U. The bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J. Natl. Cancer Inst., 86: 499-504, 1994.
16. Pezzella, F., Turley, H., Kuzu, I., Tungekar, F. M., Dunnil, S. M., Pierce, C. B., Harris, A. J., Gatter, K. C., and Mason, D. Y. bcl-2 protein in non small-cell lung carcinoma. N. Engl. J. Med., 329: 690-694, 1993.
17. WHO: The World Health Organization. Histological typing of lung tumours. Am. J. Clin. Pathol., 77: 123-136, 1982.
18. Cattoretti, G., Becker, M. H. G., Key, G., Duchrow, M., Schulter, C., Galle, J., and Gerdes, J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and Mib3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J. Pathol., 168: 357-363, 1992.
19. Cordell, J. L., Falini, B., Eeber, W. N., Ghosh, A. K., Abdulaziz, Z., McDonald, S., Pulford, K. A., Stein, H., and Mason, D. Y. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complex). J. Histochem. Cytochem., 32: 219-222, 1984.
20. Pezzella, F., Jones, M., Ralfkier, E., Ersbol, J., Garter, K. C., and Mason, D. J. Evaluation of bcl2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma. Br. J. Cancer, 65: 87-89, 1992.
21. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
22. Fontanini, G , Bigini, D., Vignati, S., Macchiarini, P., Pepe, S., Angeletti, C. A., Pingitore, R., and Squartini, F. p53 expression in non small cell lung cancer: clinical and biological correlations. Anticancer Res., 13: 737-742, 1993.
23. Colombel, M., Symmans, F., Gil, S., O'Toole, M., Chopin, D., Benson, M., Olsson, C. A., Korsmeyer, S., and Buttyan, R. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory humane prostate cancers. Am. J Pathol., 143: 390-400, 1993.
24. Pilotti, S., Collini, P., Rilke, F., Cattoretti, G., Del Bo, R., and Pierotti, M. A. bcl-2 protein expression in carcinomas originating from the follicular epithelium, of the thyroid gland. J. Pathol., 172: 337-342, 1994.
25. Joensuu, H., Pylkkanen, L., and Toikkanen, S. bcl-2 protein expression and long-term survival in breast cancer. Am. J. Pathol., 145: 1191-1198, 1994.
26. Leek, R D., Kaklamanis, L., Pezzella, F., Gatter, K. C., and Harris, A. L. bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor- negative tumors and in situ cancer. Br. J. Cancer, 69 135-139, 1994.
27. Fontanini, G., Vignati, S., Bigini, D., Mussi, A., Lucchi, M., Angeletti, C. A , Basolo, F., and Bevilacqua, G. bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Br. J Cancer. 71: 1003-1006, 1995.
28. Weidner, N. Intratumor microvessel density as a prognostic factor in cancer. Am. J. Pathol., 147: 9-19, 1995.
29. Silvestrini, R., Benini, E., Daidone, M. G., Veneroni, S., Boracchi, P., Cappelletti, V., Di Fronzo, G., and Veronesi, U. p53 as an independent prognostic marker in lymph node negative breast cancer patients. J. Natl. Cancer Inst., 85: 965-970, 1993.
30. Thor, A. D., Moore, D. H., Edgerton, S. M., Kawasaki, E. S., Reihsaus, E., Lynch, H. T., Marcus, J. N., Schwartz, L., Chen, L. C., Mayall, B. H., and Smith, H. S. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancer. J. Natl. Cancer Inst., 84: 845-855, 1992.
31. Allred, D. C., Claeck, G. M., Elledge, R., Fuqua, S. A. W., Brown, R. W., Chamness, G. C., Osborne, K. C., and McGuire, W. L. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J. Natl. Cancer Inst., 85: 200-206, 1993.
32. Starzynska, T., Bromley, M , Ghosh, A., and Stern, P. L. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br. J. Cancer, 66: 558-562, 1992.
33. Uhlman, D., Nguyen, P. L., Manivel, J. C., Aeppli, D., Resnik, J. M., Fraley, E. E., Gang, Z., and Niehans, G. A. Association of immunohistochemical staining for p53 with metastatic progression and poor survival in patients with renal cell carcinoma. J. Natl. Cancer Inst., 86: 1470-1475, 1994.
34. Ito, K., Watanabe, K., Nasim, S., Sasano, H., Sato, S., Yajima, A., Silverberg, S. G., and Garrett, C. T. Prognostic significance of p53 overexpression in endometrial cancer. Cancer Res., 54: 4667-4670, 1994.
35. Oliner, D. J., Kanzler, K. W., Meltzer, P. S., George, D. L., and Volgestein, B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (Lond.), 538: 80-83, 1992.
36. Weidner, N., Carrol, P. R., Flax, J., Blumenfeld, W., and Folkman, J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol., 243: 401-409, 1993.
37. Gasparini, G., Weidner, N., Maluta, S., Pozza, F., Boracchi, P., Mezzetti, M., Testolin, A , and Bevilacqua, P. Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int. J. Cancer, 55: 739-744, 1993.
38. Srivastava, A , Laidler, P., Davies, R. P., Morgan, K., and Hughes, L. E. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. Am. J. Pathol., 133: 419-423, 1988.
39. Horak, E. R., Leek, R., Klenk, N., Lejeune, S., Smith, K., Stuart. N., Greenall, H., Stepniewzka, K., and Harris, A. L. Angiogenesis assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet, 340: 1120-1124, 1992.
40. Folkman, J. Seminars in medicine of the Beth Israel Hospital Boston: Clinical applications of research on angiogenesis. N. Engl. J. Med , 333: 1757-1763, 1995.
41. Hall, N. R., Fish, D. E., Hunt, N., Goldin, R. D., Guillou, P. J., and Monson, J. R. Is the relation between angiogenesis and metastasis in breast cancer real? Surg. Oncol., 1: 223-229, 1992.
42. Van Hoef, M. E. H. M., Knox, W. F., Dhesi, S. S., Howell, A., and Shar, A. M. Assessment of tumour vasculature as a prognostic in lymph node negative invasive breast cancer. Eur. J. Cancer, 29A: 1141-1145, 1993.
43. Axelsson, K., Ljung, B. M., Moore, D. H., II, Thor, A. D., Chew, K. L., Edgerton S. M., and Mayall, B. H. Tumor angiogenesis as prognostic assay for invasive ductal breast carcinoma. J. Natl. Cancer Inst., 87: 997-1008, 1995.
44. Siitonen, S. M., Haapsalo, H. K., Rantala, I. S., Helin, H. J., and Isola, J J. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of selected node-negative breast carcinomas. Mod. Pathol., 8: 745-752, 1995.